PicoCELA Inc. PCLA
Building Products · IPO 2025 · data as of November 13, 2026
PicoCELA Inc. (PCLA) is a consumer discretionary company listed in the US with a market value of about $58M. In fiscal year 2025 it had revenue of $4M and net income of -$4M, a net margin of -115.0%.
Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -44%.
About PicoCELA
PicoCELA is listed in the US and classified in building products, IPO year 2025. Revenue went from $5M in 2022 to $4M in 2025, a decline of about 7.9% a year. It was profitable in 0 of the last 4 years in our data. It spends 5% of revenue on research and development.
Score: 0.6 / 5
Checks passed
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 4 years
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $4M | $5M | $4M | $5M |
| Net income | -$4M | -$3M | -$4M | -$35808 |
| Free cash flow | -$4M | -$2M | -$5M | -$821367 |
| EPS (diluted) | $-0.44 | $-0.35 | $-0.44 | $-0.00 |
| Net margin | -115.0% | -61.2% | -113.3% | -0.8% |
| ROIC | -63.2% | -57.7% | -52.4% | -2.7% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does PicoCELA pay a dividend?
Not currently.
Is PicoCELA a good stock to buy?
We do not give buy or sell advice. PicoCELA scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.